Literature DB >> 16898572

The DREAM trial and the prospect of diabetes prevention.

Samy I McFarlane, Tanja Rundek, John Nicasio, Mrunalini Deshmukh, James R Sowers.   

Abstract

Entities:  

Year:  2006        PMID： 16898572     DOI： 10.1007/s11892-006-0035-6

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  10 in total

1.  Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers.

Authors:  Samy I McFarlane; Scott J Jacober; Nathaniel Winer; Jasjeet Kaur; Jonathan P Castro; MaryLou A Wui; Agnes Gliwa; Hans Von Gizycki; James R Sowers
Journal:  Diabetes Care       Date:  2002-04       Impact factor: 19.112

2.  Dysglycaemia and risk of cardiovascular disease.

Authors:  H C Gerstein; S Yusuf
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

3.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

Review 4.  Nonhypoglycemic effects of thiazolidinediones.

Authors:  A A Parulkar; M L Pendergrass; R Granda-Ayala; T R Lee; V A Fonseca
Journal:  Ann Intern Med       Date:  2001-01-02       Impact factor: 25.391

5.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

Review 6.  Pancreatic beta-cell loss and preservation in type 2 diabetes.

Authors:  Thomas A Buchanan
Journal:  Clin Ther       Date:  2003       Impact factor: 3.393

7.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

Review 8.  Prevention of type 2 diabetes.

Authors:  Samy I McFarlane; John J Shin; Tanja Rundek; J Thomas Bigger
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

Review 9.  Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease.

Authors:  Samy I McFarlane; Ashok Kumar; James R Sowers
Journal:  Am J Cardiol       Date:  2003-06-19       Impact factor: 2.778

10.  Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men.

Authors:  Samy I McFarlane; Jonathan Castro; Jasjeet Kaur; John J Shin; Douglas Kelling; Amal Farag; Nicole Simon; Fadi El-Atat; Alan Sacerdote; Emad Basta; John Flack; George Bakris; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-02       Impact factor: 3.738
  10 in total
  1 in total

1.  Measurement of subclinical carotid atherosclerosis may help in predicting risk for stroke in patients with diabetes.

Authors:  David Della-Morte; Camillo Ricordi; Fiorella Guadagni; Tatjana Rundek
Journal:  Metab Brain Dis       Date:  2013-02-10       Impact factor: 3.584
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.